Posted inStock
LLY Stock Rises to $919 Today Despite Retatrutide Breakthrough, Rally Stalls After Strong Trial Data
Eli Lilly stock rose to $919 today, but the reaction remained muted despite the company delivering strong late-stage results for its next-generation obesity drug, retatrutide. While the headline numbers showed…







